JCJingjing Cao

Jingjing Cao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jingjing Cao has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Menghan Shi

    State Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, China

    3 shared publications
  • Fen Shan

    Guangzhou Zoo, Guangzhou 510075, China

    2 shared publications
  • Niu Zhou

    Guangzhou Zoo, Guangzhou, China

    2 shared publications
  • Wanping Li

    Guangzhou Zoo, Guangzhou, China

    2 shared publications
  • Xiangzhi Li

    Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Advanced Medical Research Institute, Shandong University, Qingdao, China

    2 shared publications
  • Youming Zhang

    State Key Laboratory of Microbial Technology Microbial Technology Institute Shandong University Qingdao Shandong China

    2 shared publications

Latest Publications

  • Open Access

    PRC2.1 Coordinates Peri‐Nucleolar H3K27me3‐Enriched Heterochromatin Organization and NPM1 Pentamerization to Maintain Nucleolar Integrity

    by Lina Zhu, Wenqin Wang, Shuyun Chen, Gangyi Zhu, Zhen Wu, Yue Gu, Jingwen Xiong, Xu Zhang, Heng Liu, Kyoichi Isono, et al.

    The nucleolus, a membrane‐less organelle within the nucleus, plays a fundamental role in ribosome biogenesis with cellular functions across diverse physiological and pathological states. While its multilayered, liquid‐like architecture is formed by complex interactions between nucleolar proteins and nucleic acids, the regulatory mechanism of nucleoplasmic components on nucleolus remains poorly understood, particularly heterochromatin and its associated proteins. In this study, we revealed that Polycomb repressive complex 2.1 (composed of PRC2 core subunits plus Polycomb‐like (PCL) homolog), associating with H3K27me3‐enriched heterochromatin, accumulates surrounding the nucleolus to form a ring‐like structure. Notably, as a key PRC2.1 component, PCL2 undergoes phase separation, while the intrinsically disordered region (IDR) in PCL2 regulates both the fluidity of the condensates and its interaction with nucleolar protein nucleophosmin (NPM1). PCL2 is a key regulator to facilitate NPM1 pentamerization and interaction among nucleolar components, ensuring the efficient progression of rRNA and protein synthesis. Taken together, our findings reveal that PRC2.1(PCL2) plays a crucial role in maintaining nucleolar integrity and rRNA synthesis, highlighting that PRC2.1(PCL2) is required for cell proliferation.

  • Open Access

    Identification of host proteins that interact with African swine fever virus pE301R

    by Menghan Shi, Niu Zhou, Mengchen Xiu, Xiangzhi Li, Fen Shan, Wu Chen, Wanping Li, Cheng-Ming Chiang, Xiaodong Wu, Youming Zhang, et al.


  • Open Access

    Isolation, genome analysis and comparison of a novel parainfluenza virus 5 from a Siberian tiger (Panthera tigris)

    by Niu Zhou, Liang Chen, Chen Wang, Mengna Lv, Fen Shan, Wanping Li, Yajiang Wu, Xueqing Du, Jinli Fan, Minting Liu, et al.

    Paramyxoviruses are important pathogens affecting various animals, including mammals and humans. Parainfluenza virus 5 (PIV5)—a member of the family Paramyxoviridae—is a major threat to the health of mammals and humans. However, studies on terrestrial wild animals infected with PIV5 are scanty. In this study, we utilized reverse transcription PCR to detect PIV5 infection in the visceral organ tissues of a Siberian tiger (Panthera tigris ssp. altaica) with vomiting, diarrhea, and dyspnea before its death. A novel PIV5 (named SR strain) with a slowly progressive cytopathic effect was isolated in Vero cells and validated using a transmission electron microscope. Full-length sequencing and analysis revealed that the whole genome of the PIV5 SR strain contained 15,246 nucleotides (nt) and seven non-overlapping genes (3’-N-V/P-M-F-SH-HN-L-5′) encoding eight proteins. Phylogenetic analysis of three PIV5 strains identified in the same zoo confirmed that PIV5 strains SR and ZJQ-221 shared the closest genetic relationship as they were clustered in the same branch, while the recently found Siberian tiger strain SZ2 kept a certain distance and formed a relatively unique branch. Furthermore, mutations of nt and amino acids (aa) between strains ZJQ-221, SR, and SZ2 were identified. In summary, we report the identification and genomic characterization of a novel PIV5 strain SR isolated in a Siberian tiger, which may help future research on interspecific transmission mechanisms.


  • The matrix protein of respiratory syncytial virus suppresses interferon signaling via RACK1 association

    by Jingjing Cao, Menghan Shi, Lina Zhu, Xiangzhi Li, Aiying Li, Shwu-Yuan Wu, Cheng-Ming Chiang, Youming Zhang

    Respiratory syncytial virus (RSV) is a frequent cause of respiratory illness among pediatric and elderly populations. The severity of the respiratory disease is determined, in part, by RSV virulence and the host immune response, especially type I interferon (IFN) production. Using proteomics for the identification of partner proteins associated with RSV-encoded matrix (M) protein in transiently M-expressed and RSV-infected cells, we identified many M-interacting proteins involved in diverse biological processes including cell stress and innate immune response, highlighting M protein as a novel antagonist of IFN-β potentially accounting for limited IFN production in RSV-infected epithelial cells. To clarify the M antagonistic mechanism, we focused on M-interacting receptor of activated C kinase 1 (RACK1), which is an adaptor protein and a negative regulator of IRF3/7. Knockdown of RACK1 with small-interfering RNA attenuated the M-suppressed IFN-β response leading to increased IFN-β production and reduced RSV genome replication, confirming RACK1 as a critical host factor for efficient RSV infection. Our finding unravels an immune-intervening effect of RSV M protein on IFN response and further identifies RACK1 as a promising target for antiviral therapy. IMPORTANCE: Respiratory syncytial virus (RSV) matrix (M) protein is indispensable for virion assembly and release. It is localized to the nucleus during early infection to perturb host transcription. However, the function of RSV M protein in other cellular activities remains poorly understood. In this study, several interferon response-associated host factors, including RACK1, were identified by proteomic analysis as RSV M interactors. Knockdown of RACK1 attenuates RSV-restricted IFN signaling leading to enhanced host defense against RSV infection, unraveling a role of M protein in antagonizing IFN response via association with RACK1. Our study uncovers a previously unrecognized mechanism of immune evasion by RSV M protein and identifies RACK1 as a novel host factor recruited by RSV, highlighting RACK1 as a potential new target for RSV therapeutics development.


  • Open Access

    Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro

    by Yuzhen Gao, Jingjing Cao, Pan Xing, Ralf Altmeyer, Youming Zhang

    Respiratory syncytial virus (RSV) is a major pathogen that causes severe lower respiratory tract infection in infants, the elderly and the immunocompromised worldwide. At present no approved specific drugs or vaccines are available to treat this pathogen. Recently, several promising candidates targeting RSV entry and multiplication steps are under investigation. However, it is possible to lead to drug resistance under the long-term treatment. Therapeutic combinations constitute an alternative to prevent resistance and reduce antiviral doses. Therefore, we tested in vitro two-drug combinations of fusion inhibitors (GS5806, Ziresovir and BMS433771) and RNA-dependent RNA polymerase complex (RdRp) inhibitors (ALS8176, RSV604, and Cyclopamine). The statistical program MacSynergy II was employed to determine synergism, additivity or antagonism between drugs. From the result, we found that combinations of ALS8176 and Ziresovir or GS5806 exhibit additive effects against RSV in vitro, with interaction volume of 50 µM2% and 31 µM2% at 95% confidence interval, respectively. On the other hand, all combinations between fusion inhibitors showed antagonistic effects against RSV in vitro, with volume of antagonism ranging from −50 µM2 % to −176 µM2 % at 95% confidence interval. Over all, our results suggest the potentially therapeutic combinations in combating RSV in vitro could be considered for further animal and clinical evaluations.